XML 41 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments
6 Months Ended
Mar. 31, 2012
Financial Instruments Disclosure [Abstract]  
Financial Instruments

NOTE 5. FINANCIAL INSTRUMENTS

 

At March 31, 2012, the Company's financial assets and liabilities reflected in the Consolidated Financial Statements at fair value consist of marketable securities and derivatives. Fair value for marketable securities is determined utilizing a market approach based on quoted market prices in active markets at period end. Fair value for derivatives is determined utilizing a market-based approach.

 

The following table summarizes the valuation of the Company's financial assets and liabilities as of March 31, 2012 and September 30, 2011:

             
     Quoted Prices In Significant Other Significant
     Active Markets for Observable Unobservable
Financial Asset (Liability)   Identical Assets  Inputs Inputs
(in millions) Total Level 1 Level 2 Level 3
March 31, 2012            
Marketable securities $ 87 $ 87 $ - $ -
Derivatives   (2)   -   (2)   -
             
Total $ 85 $ 87 $ (2) $ -
             
September 30, 2011            
Marketable securities $ 68 $ 68 $ - $ -
Derivatives   (4)   -   (4)   -
             
Total $ 64 $ 68 $ (4) $ -